Alterity Therapeutics (ATHE) Restructuring Costs (2013 - 2025)

Alterity Therapeutics has reported Restructuring Costs for 10 years, with the latest figure at $300347.2 in Q4 2025.

• On a quarterly basis, Restructuring Costs rose 1.98% year-over-year to $300347.2 in Q4 2025; TTM through Dec 2025 was $880752.6, a 19.17% increase from a year earlier, with the FY2024 full-year figure at $520860.0, up 70.45% from the prior year.
• Restructuring Costs was $300347.2 for Q4 2025 at Alterity Therapeutics, up from $294528.3 in the prior quarter.
• The five-year high for Restructuring Costs was $300347.2 in Q4 2025, with the low at $126118.3 in Q4 2023.
• Average Restructuring Costs over 5 years is $207880.5, with a median of $159758.8 recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Restructuring Costs retreated 21.06% in 2023, then jumped 133.53% in 2024.
• Over 5 years, Restructuring Costs stood at $158650.0 in 2021, then rose by 0.7% to $159758.8 in 2022, then declined by 21.06% to $126118.3 in 2023, then surged by 133.53% to $294528.3 in 2024, then climbed by 1.98% to $300347.2 in 2025.
• The last three Restructuring Costs figures came in at $300347.2 (Q4 2025), $294528.3 (Q4 2024), and $126118.3 (Q4 2023), per Business Quant data.